ABT-510, a modified type 1 repeat peptide of thrombospondin, inhibits malignant glioma growth in vivo by inhibiting angiogenesis

Joshua C. Anderson, J. Robert Grammer, Wenquan Wang, L. Burton Nabors, Jack Henkin, Jerry E. Stewart, Candece L. Gladson*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

53 Scopus citations

Fingerprint

Dive into the research topics of 'ABT-510, a modified type 1 repeat peptide of thrombospondin, inhibits malignant glioma growth in vivo by inhibiting angiogenesis'. Together they form a unique fingerprint.

Keyphrases

Neuroscience

Immunology and Microbiology

Pharmacology, Toxicology and Pharmaceutical Science